Riddhi Siddhi Gluco Biols Ltd Fair Value
RIDDHI · Services · Current price ₹730
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹1,909 | 4% ROE fading to 12% over ~3 yrs, on ₹2117 book |
| Relative P/E | ₹3,482 | EPS × 41.4 peer-median P/E |
| Graham floor | ₹2,002 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is Riddhi Siddhi Gluco Biols Ltd undervalued?
DocStoX estimates the fair value of Riddhi Siddhi Gluco Biols Ltd at ₹2,366 per share, versus the current market price of ₹730. That puts the stock about +224.1% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹1,909), Relative P/E (₹3,482), Graham floor (₹2,002). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹1,909 (bear) to ₹2,366 (base) to ₹3,482 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on Riddhi Siddhi Gluco Biols Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.